Enquire
Now

Download

The effect of COVID-19 on the Healthcare market access landscape

14 June 2021

Shape 1
Featured Image - The effect of COVID-19 on the Healthcare market access landscape

No one needs reminding that the COVID-19 pandemic is the most dramatic global event since at least 9/11/2001. But none of us really know what it means for healthcare provision, product approvals and the role of pharma as we move into the post-COVID era.

To explore these issues, in late 2020 the Blueprint Partnership team undertook a self-funded study where we discussed these questions with 14 national and regional payers (6 US, 8 EU5). The results raise interesting questions about our industry in the future.

Download the PDF